nodes	percent_of_prediction	percent_of_DWPC	metapath
Alclometasone—Hydrocortisone—ANXA1—esophageal cancer	0.0695	0.192	CrCbGaD
Alclometasone—Dexamethasone—ANXA1—esophageal cancer	0.0518	0.143	CrCbGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—KRT17—esophageal cancer	0.0323	0.0506	CbGpPWpGaD
Alclometasone—Prednisolone—CYP2A6—esophageal cancer	0.0279	0.0772	CrCbGaD
Alclometasone—Betamethasone—CYP19A1—esophageal cancer	0.026	0.072	CrCbGaD
Alclometasone—Dexamethasone—NOS2—esophageal cancer	0.0243	0.0671	CrCbGaD
Alclometasone—CYP3A4—Codeine and Morphine Metabolism—ABCC2—esophageal cancer	0.0208	0.0325	CbGpPWpGaD
Alclometasone—Dexamethasone—CYP1B1—esophageal cancer	0.0206	0.0571	CrCbGaD
Alclometasone—NR3C1—Nuclear Receptors—NR1I2—esophageal cancer	0.0202	0.0317	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—CRTC1—esophageal cancer	0.0179	0.028	CbGpPWpGaD
Alclometasone—CYP3A4—Fatty Acid Omega Oxidation—ADH7—esophageal cancer	0.0164	0.0257	CbGpPWpGaD
Alclometasone—Dexamethasone—ABCC2—esophageal cancer	0.0161	0.0445	CrCbGaD
Alclometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALDOB—esophageal cancer	0.016	0.0251	CbGpPWpGaD
Alclometasone—NR3C1—Nuclear Receptor transcription pathway—NR1I2—esophageal cancer	0.016	0.025	CbGpPWpGaD
Alclometasone—Dexamethasone—CYP2A6—esophageal cancer	0.0159	0.044	CrCbGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—KRT14—esophageal cancer	0.0158	0.0247	CbGpPWpGaD
Alclometasone—Dexamethasone—CYP19A1—esophageal cancer	0.0151	0.0419	CrCbGaD
Alclometasone—Methylprednisolone—ABCB1—esophageal cancer	0.0147	0.0408	CrCbGaD
Alclometasone—Triamcinolone—PTGS2—esophageal cancer	0.0146	0.0404	CrCbGaD
Alclometasone—CYP3A4—Tryptophan metabolism—ALDH3A2—esophageal cancer	0.0144	0.0226	CbGpPWpGaD
Alclometasone—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—esophageal cancer	0.0144	0.0225	CbGpPWpGaD
Alclometasone—CYP3A4—Irinotecan Pathway—ABCC2—esophageal cancer	0.0133	0.0208	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX1—esophageal cancer	0.013	0.0203	CbGpPWpGaD
Alclometasone—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—esophageal cancer	0.0128	0.02	CbGpPWpGaD
Alclometasone—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—esophageal cancer	0.0122	0.0191	CbGpPWpGaD
Alclometasone—Betamethasone—PTGS2—esophageal cancer	0.012	0.0331	CrCbGaD
Alclometasone—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—esophageal cancer	0.0114	0.0178	CbGpPWpGaD
Alclometasone—Prednisone—ABCB1—esophageal cancer	0.0113	0.0312	CrCbGaD
Alclometasone—CYP3A4—Codeine and Morphine Metabolism—ABCB1—esophageal cancer	0.011	0.0173	CbGpPWpGaD
Alclometasone—NR3C1—Endoderm Differentiation—SOX2—esophageal cancer	0.0105	0.0165	CbGpPWpGaD
Alclometasone—Prednisolone—ABCB1—esophageal cancer	0.0104	0.0288	CrCbGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—esophageal cancer	0.0103	0.0161	CbGpPWpGaD
Alclometasone—Betamethasone—ABCB1—esophageal cancer	0.0102	0.0282	CrCbGaD
Alclometasone—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—esophageal cancer	0.0101	0.0159	CbGpPWpGaD
Alclometasone—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—esophageal cancer	0.00954	0.0149	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—ADCYAP1—esophageal cancer	0.00944	0.0148	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—SFN—esophageal cancer	0.00878	0.0137	CbGpPWpGaD
Alclometasone—CYP3A4—Xenobiotics—CYP2A6—esophageal cancer	0.00798	0.0125	CbGpPWpGaD
Alclometasone—Hydrocortisone—ABCB1—esophageal cancer	0.00795	0.022	CrCbGaD
Alclometasone—CYP3A4—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.00767	0.012	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—CYP26A1—esophageal cancer	0.00757	0.0118	CbGpPWpGaD
Alclometasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.00732	0.0115	CbGpPWpGaD
Alclometasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.00732	0.0115	CbGpPWpGaD
Alclometasone—CYP3A4—Estrogen metabolism—CYP1B1—esophageal cancer	0.007	0.011	CbGpPWpGaD
Alclometasone—Dexamethasone—PTGS2—esophageal cancer	0.00696	0.0193	CrCbGaD
Alclometasone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.00685	0.0107	CbGpPWpGaD
Alclometasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—esophageal cancer	0.00654	0.0102	CbGpPWpGaD
Alclometasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.00653	0.0102	CbGpPWpGaD
Alclometasone—CYP3A4—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.00618	0.00968	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—RUNX3—esophageal cancer	0.00608	0.00952	CbGpPWpGaD
Alclometasone—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—esophageal cancer	0.00603	0.00944	CbGpPWpGaD
Alclometasone—NR3C1—Endoderm Differentiation—SMAD4—esophageal cancer	0.00601	0.00941	CbGpPWpGaD
Alclometasone—Dexamethasone—ABCB1—esophageal cancer	0.00592	0.0164	CrCbGaD
Alclometasone—NR3C1—Circadian Clock—HIF1A—esophageal cancer	0.00583	0.00912	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—GAPDH—esophageal cancer	0.00561	0.00879	CbGpPWpGaD
Alclometasone—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.00548	0.00858	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—SOX2—esophageal cancer	0.00542	0.00849	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD4—esophageal cancer	0.00523	0.00818	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of Androgen receptor activity—CREBBP—esophageal cancer	0.0049	0.00768	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—BAX—esophageal cancer	0.0049	0.00767	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—HIF1A—esophageal cancer	0.00481	0.00752	CbGpPWpGaD
Alclometasone—NR3C1—Circadian Clock—CREBBP—esophageal cancer	0.00476	0.00745	CbGpPWpGaD
Alclometasone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.00465	0.00728	CbGpPWpGaD
Alclometasone—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.00462	0.00724	CbGpPWpGaD
Alclometasone—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.00459	0.00718	CbGpPWpGaD
Alclometasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—esophageal cancer	0.00445	0.00697	CbGpPWpGaD
Alclometasone—NR3C1—Endoderm Differentiation—NOTCH1—esophageal cancer	0.00443	0.00694	CbGpPWpGaD
Alclometasone—CYP3A4—Tryptophan metabolism—ALDH2—esophageal cancer	0.00436	0.00682	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—SST—esophageal cancer	0.00421	0.0066	CbGpPWpGaD
Alclometasone—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.00405	0.00635	CbGpPWpGaD
Alclometasone—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.00377	0.0059	CbGpPWpGaD
Alclometasone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.00364	0.00569	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—esophageal cancer	0.00349	0.00547	CbGpPWpGaD
Alclometasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.00346	0.00542	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—esophageal cancer	0.00346	0.00541	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—CDKN2A—esophageal cancer	0.00344	0.00538	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of Androgen receptor activity—EP300—esophageal cancer	0.00334	0.00523	CbGpPWpGaD
Alclometasone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.00331	0.00519	CbGpPWpGaD
Alclometasone—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.0033	0.00517	CbGpPWpGaD
Alclometasone—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.00327	0.00512	CbGpPWpGaD
Alclometasone—NR3C1—Circadian Clock—EP300—esophageal cancer	0.00324	0.00508	CbGpPWpGaD
Alclometasone—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.00311	0.00486	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—HIF1A—esophageal cancer	0.00293	0.00459	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—CCND1—esophageal cancer	0.0029	0.00455	CbGpPWpGaD
Alclometasone—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.00286	0.00447	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—NR1I2—esophageal cancer	0.00276	0.00433	CbGpPWpGaD
Alclometasone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.00269	0.0042	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—EP300—esophageal cancer	0.00267	0.00419	CbGpPWpGaD
Alclometasone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.00267	0.00418	CbGpPWpGaD
Alclometasone—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.00264	0.00413	CbGpPWpGaD
Alclometasone—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.00255	0.00399	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—HIF1A—esophageal cancer	0.00253	0.00396	CbGpPWpGaD
Alclometasone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.00251	0.00393	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—esophageal cancer	0.0025	0.00391	CbGpPWpGaD
Alclometasone—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.00248	0.00388	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—esophageal cancer	0.00248	0.00388	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.00246	0.00385	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—RB1—esophageal cancer	0.00238	0.00373	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—esophageal cancer	0.00238	0.00372	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—EP300—esophageal cancer	0.00236	0.00369	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—MYC—esophageal cancer	0.00233	0.00365	CbGpPWpGaD
Alclometasone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00216	0.00339	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.00215	0.00337	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—esophageal cancer	0.00207	0.00325	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—CREBBP—esophageal cancer	0.00207	0.00324	CbGpPWpGaD
Alclometasone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.00204	0.00319	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.002	0.00313	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00197	0.00309	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—TP53—esophageal cancer	0.00191	0.003	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.00186	0.00291	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.00184	0.00287	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—SMG6—esophageal cancer	0.00176	0.00275	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—NOTCH3—esophageal cancer	0.00174	0.00272	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—CDKN1A—esophageal cancer	0.00171	0.00268	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—esophageal cancer	0.00169	0.00264	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—NOTCH2—esophageal cancer	0.00156	0.00244	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.00152	0.00238	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.00144	0.00226	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.00143	0.00223	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.00141	0.0022	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.00135	0.00212	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—NR1I2—esophageal cancer	0.00133	0.00208	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—SMAD4—esophageal cancer	0.00131	0.00205	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.00115	0.0018	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—HIST1H2BM—esophageal cancer	0.00114	0.00179	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.00113	0.00178	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.00108	0.00169	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.00107	0.00167	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—NOTCH1—esophageal cancer	0.000963	0.00151	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—PSME2—esophageal cancer	0.000885	0.00139	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—PSME1—esophageal cancer	0.000885	0.00139	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—CREBBP—esophageal cancer	0.000873	0.00137	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—NOTCH3—esophageal cancer	0.000835	0.00131	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—NOTCH2—esophageal cancer	0.000749	0.00117	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—SMAD4—esophageal cancer	0.000629	0.000985	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000581	0.00091	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000581	0.00091	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—MYC—esophageal cancer	0.000518	0.000812	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CA1—esophageal cancer	0.000494	0.000773	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.000494	0.000773	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—NOTCH1—esophageal cancer	0.000464	0.000726	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CA2—esophageal cancer	0.000452	0.000707	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—CREBBP—esophageal cancer	0.000421	0.000658	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PLCE1—esophageal cancer	0.00042	0.000658	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ADH7—esophageal cancer	0.00042	0.000658	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ADH1B—esophageal cancer	0.000368	0.000577	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—TYMP—esophageal cancer	0.000352	0.000551	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CYP26A1—esophageal cancer	0.000342	0.000536	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ALOX15—esophageal cancer	0.000334	0.000522	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GSTO1—esophageal cancer	0.000318	0.000498	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—TPI1—esophageal cancer	0.000318	0.000498	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ALDOB—esophageal cancer	0.000305	0.000478	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GAPDH—esophageal cancer	0.000294	0.00046	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CRABP1—esophageal cancer	0.000291	0.000456	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GNG7—esophageal cancer	0.000277	0.000434	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ALDH2—esophageal cancer	0.000259	0.000406	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—MYC—esophageal cancer	0.00025	0.000391	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GSTT1—esophageal cancer	0.000247	0.000386	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CYP2A6—esophageal cancer	0.000244	0.000382	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ENO1—esophageal cancer	0.000231	0.000362	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PTGS1—esophageal cancer	0.000231	0.000362	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PSME2—esophageal cancer	0.000228	0.000357	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PSME1—esophageal cancer	0.000228	0.000357	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CYP1B1—esophageal cancer	0.000197	0.000308	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CYP19A1—esophageal cancer	0.000185	0.000289	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—HMOX1—esophageal cancer	0.000169	0.000264	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ABCB1—esophageal cancer	0.000162	0.000254	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CREBBP—esophageal cancer	0.000108	0.000169	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—NOS3—esophageal cancer	9.69e-05	0.000152	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PTGS2—esophageal cancer	8.86e-05	0.000139	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—EP300—esophageal cancer	7.37e-05	0.000115	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PIK3CA—esophageal cancer	5.45e-05	8.54e-05	CbGpPWpGaD
